Online Exclusive Article

Technical Evaluation of a New Sterile Medical Device to Improve Anticancer Chemotherapy Administration

Nicolas Simon

Bertrand Décaudin

Damien Lannoy

Frédérique Danicourt

Christine Barthélémy

Pascal Odou

chemotherapy, safe handling
ONF 2010, 37(6), E370-E376. DOI: 10.1188/10.ONF.E370-E376

Purpose/Objectives: To assess the PCHIMX-1® (Doran International), a new sterile medical device intended by its manufacturer to improve the quality and safety of cytotoxic drug infusions, as well as its influence on manipulation times required for pharmacy technicians and nurses and its effect on infusion line outflow parameters.

Design: PCHIMX-1 assemblies were compared to standard infusion sets.

Setting: Pharmacy and oncology units of a French general hospital.

Methods: Reference assemblies (an infusion bag connected to an infusion set) were compared to PCHIMX-1 assemblies (PCHIMX-1 connected to two bags and to an infusion set). Two assessments were performed: (a) comparison of the times of manipulation during both preparation and administration of 5-fluorouracil infusion bags (n = 40) and (b) effect of PCHIMX-1 on infusion quality.

Main Research Variables: Manipulation times in the pharmacy (TP) and in the ward (TW) were measured, as well as flow rate and infusion efficiency.

Findings: The results showed that TW was significantly increased, whereas TP was significantly decreased; total time was unchanged. Results also showed that PCHIMX-1 significantly changed infusion efficiency; flow rate was not affected.

Conclusions: PCHIMX-1 obliges pharmacy technicians and nurses to change their handling procedures. The device does not have any influence on infusion flow rate but considerably improves infusion quality by ensuring that the full quantity of medication prescribed is administered.

Implications for Nursing: PCHIMX-1 guarantees that the complete prescribed dose of chemotherapy is administered without any change in infusion quality and adheres to the latest recommendations concerning occupational exposure protection.

Jump to a section

    References

    American Society of Health-System Pharmacists. (2006). ASHP guidelines on handling hazardous drugs. American Journal of Health-System Pharmacy, 63, 1172-1193.
    Cavallo, D., Ursini, C. L., Perniconi, B., Di Francesco, A. D., Giglio, M., Rubino, F. M., … Iavicoli, S. (2005). Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutation Research, 587(1-2), 45-51. dx.doi.org/10.1016/j.mrgentox.2005.07.008
    Connor, T. H., Anderson, R. W., Sessink, P. J., Broadfield, L., & Power, L. A. (1999). Surface contamination with antineoplastic agents in six cancer treatment centres in Canada and the United States. American Journal of Health-System Pharmacy, 56, 1427-1432.
    Crass, R. E., & Vance, J. R. (1985). In vivo accuracy of gravity-flow i.v. infusion systems. American Journal of Hospital Pharmacy, 42, 328-331.
    Crauste-Manciet, S., Sessink, P. J., Ferrari, S., Jomier, J. Y., & Brossard, D. (2005). Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Annals of Occupational Hygiene, 49, 619-628. dx.doi.org/10.1093/annhyg/mei045
    Elad, D., Zaretsky, U., & Heller, O. (1994). Hydrodynamic evaluation of intravenous infusion systems. Annals of Emergency Medicine, 23, 457-463.
    Fransman, W., Roeleveld, N., Peelen, S., de Kort, W., Kromhout, H., & Heederik, D. (2007). Nurses with dermal exposure to antineoplastic drugs: Reproductive outcomes. Epidemiology, 18, 112-119. dx.doi.org/10.1097/01.ede.0000246827.44093.c1
    Hedmer, M., Tinnerberg, H., Axmon, A., & Jönsson, B. A. (2008). Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. International Archives of Occupational and Environmental Health, 81, 899-911. dx.doi.org/1007/s00420-007-0284-y
    International Society of Oncology Pharmacy Practicioners Standards Committee. (2007). ISOPP standards of practice. Safe handling of cytotoxics. Journal of Oncology Pharmacy Practice, 13(Suppl.) 1-81. dx.doi.org/10.1177/1078155207082350
    Jochimsen, P. R. (1992). Handling of cytotoxic drugs by healthcare workers. A review of the risks of exposure. Drug Safety, 7, 374-380.
    Mason, H. J., Blair, S., Sams, C., Jones, K., Garfitt, S. J., Cuschieri, M. J., & Baxter, P. J. (2005). Exposure to antineoplastic drugs in two UK hospital pharmacy units. Annals of Occupational Hygiene, 49, 603-610. dx.doi.org/10.1093/annhyg/mei023
    Mason, H. J., Morton, J., Garfitt, S. J., Iqbal, S., & Jones, K. (2003). Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Annals of Occupational Hygiene, 47, 681-685. dx.doi.org/10.1093/annhyg/meg078
    Nygren, O., Gustavsson, B., Ström, L., Eriksson, R., Jarneborn, L., & Friberg, A. (2002). Exposure to anti-cancer drugs during preparation and administration. Investigations of an open and a closed system. Journal of Environmental Monitoring, 4, 739-742. dx.doi.org/10.1039/b205132j
    Nygren, O., Olofsson, E., & Johansson, L. (2008). Spill and leakage using a drug preparation system based on a double-filter technology. Annals of Occupational Hygiene, 52, 95-98. dx.doi.org/10.1093/annhyg/mem067
    Occupational Safety and Health Administration. (1996). Controlling occupational exposure to hazardous drugs. American Journal of Health-System Pharmacy, 53, 1669-1685.
    Pleasants, R. A., Sawyer, W. T., Williams, D. M., McKenna, W. R., Brown, J. M., & Powell, J. R. (1988). Accuracy of tobramycin delivery by four i.v. infusion methods. Clinical Pharmacy, 7, 367-373.
    Pleasants, R. A., Sawyer, W. T., Williams, D. M., McKenna, W. R., & Powell, J. R. (1988). Effect of four intravenous infusion methods on tobramycin pharmacokinetics. Clinical Pharmacy, 7, 374-379.
    Roberts, S., Khammo, N., McDonnell, G., & Sewell, G. J. (2006). Studies on the decontamination of surfaces exposed to cytotoxic drugs in chemotherapy workstations. Journal of Oncology Pharmacy Practice, 12, 95-104. dx.doi.org/10.1177/1078155206070439
    Selevan, S. G., Lindbohm, M. L., Hornung, R. W., & Hemminki, K. (1985). A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. New England Journal of Medicine, 313, 1173-1178. dx.doi.org/10.1056/NEJM198511073131901
    Sessink, P. J., Friemèl, N. S., Anzion, R. B., & Bos, R. P. (1994). Biological and environmental monitoring of occupational exposure of pharmaceutical plant workers to methotrexate. International Archives of Occupational and Environmental Health, 65, 401-403. dx.doi.org/10.1007/BF00383251
    Sessink, P. J., Rolf, M., & Ryden, N. S. (1999). Evaluation of the PhaSeal hazardous drugs containment system. Hospital Pharmacy, 34, 1311-1317.
    Sessink, P. J., Timmersmans, J. L., Anzion, R. B., & Bos, R. P. (1994). Assessment of occupational exposure of pharmaceutical plant workers to 5-fluorouracil. Determination of a-fluoro-b-alanine in urine. Journal of Occupational Medicine, 36, 79-83.
    Sessink, P. J., van de Kerkhof, M. C., Anzion, R. B., Noordhoek, J., & Bos, R. P. (1994). Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: Is skin absorption an important exposure route? Archives of Environmental Health, 49, 165-169. dx.doi.org/10.1080/00039896.1994.9940377
    Simon, N., Décaudin, B., & Odou, P. (2008). Medical devices for the safe reconstitution of cytotoxics. European Journal of Hospital Pharmacy Practice, Fall, S25 S27.
    Spivey, S., & Connor, T. H. (2003). Determining sources of workplace contamination with antineoplastic drugs and comparing conventional IV drug preparation with a closed system. Hospital Pharmacy, 38(2), 135-139.
    Valanis, B., Vollmer, W. M., & Steele, P. (1999). Occupational exposure to antineoplastic agents: Self-reported miscarriages and stillbirths among nurses and pharmacists. Journal of Occupational and Environmental Medicine, 41, 632-638.
    Vermeulen, R., Heideman, J., Bos, R. P., & Kromhout, H. (2000). Identification of dermal exposure pathways in the rubber manufacturing industry. Annals of Occupational Hygiene, 44, 533-541.
    Ziegler, E., Mason, H. J., & Baxter, P. J. (2002). Occupational exposure to cytotoxic drugs in two UK oncology wards. Occupational and Environmental Medicine, 59, 608-612.
    Ziser, M., Feezor, M., & Skolaut, M. W. (1979). Regulating intravenous fluid flow: Controller versus clamps. American Journal of Hospital Pharmacy, 36, 1090-1094.